What effects does radiofrequency have in liver surgeries? Can it help prevent cancer recurrence?
Zusammenfassung der Studie
Liver cancer is the sixth most common cancer worldwide and the third leading cause of cancer-related death. Furthermore, the liver is also the primary site for metastases from colorectal cancer, which is the third most common malignant disease worldwide. The standard treatment for liver cancer and liver metastases from colorectal cancer is the surgical removal of the tumor-bearing part of the liver. However, after such surgeries, cancer often recurs. Further research is needed to find a solution to this problem. It may help to treat the tumor margins after surgery with a radiofrequency device to reduce the number of tumor recurrences. This method applies high-frequency electromagnetic waves to the tissue at the tumor margins. The device heats the tissue and thereby kills cancer cells that may have remained after surgery. In the study, participants are randomly assigned to two groups. In the experimental group, liver cell cancer or liver metastases are surgically removed and the tumor margins are additionally cauterized using radiofrequency. In the control group, the cancer is only surgically removed. No additional treatment of the tumor margins is performed. Only the study staff will know which group the participants were assigned to. The aim of the study is to determine whether the additional cauterization of the tumor margins with a radiofrequency device can reduce the local recurrence rate of this cancer.
(BASEC)
Untersuchte Intervention
Surgical removal of liver cell cancer or liver metastases from colon cancer. In the experimental group, the tumor margins are also cauterized using radiofrequency, while in the control group no further treatment of the tumor margins is performed.
(BASEC)
Untersuchte Krankheit(en)
Liver cell cancer or liver metastases caused by colon or rectal cancer
(BASEC)
1. Written consent after detailed information about the study 2. 18 years or older 3. WHO Performance Status: 0-2 4. Continuous inclusion of patients (evenly distributed between both sexes) with liver metastases from colorectal cancer or patients with liver cell tumors. 5. Previous chemotherapies are allowed 6. ASA (American Society of Anesthesiology Classification) classification of the patient: 1-3 (BASEC)
Ausschlusskriterien
1. Previous or concurrent cancers that are not the primary tumor of the liver metastases, except for early-stage cervical cancer, treated skin cancer, or superficial bladder tumors. Cancers successfully treated more than 3 years ago are allowed. 2. ASA (American Society of Anesthesiology Classification) classification of the patient: 4 3. Unresectable metastases outside the liver 4. Liver metastases not originating from colorectal cancer 5. The primary liver tumor must not be benign (BASEC)
Studienstandort
Winterthur
(BASEC)
Sponsor
nicht verfügbar
Kontakt für weitere Auskünfte zur Studie
Kontaktperson Schweiz
PD Dr. Dr. med. Lukasz Filip Grochola
+41522664162
lukaszfilip.grochola@clutterksw.ch(BASEC)
Wissenschaftliche Auskünfte
nicht verfügbar
Name der bewilligenden Ethikkommission (bei multizentrischen Studien nur die Leitkommission)
Ethikkommission Zürich
(BASEC)
Datum der Bewilligung durch die Ethikkommission
22.11.2024
(BASEC)
ICTRP Studien-ID
nicht verfügbar
Offizieller Titel (Genehmigt von der Ethikkommission)
nicht verfügbar
Wissenschaftlicher Titel
nicht verfügbar
Öffentlicher Titel
nicht verfügbar
Untersuchte Krankheit(en)
nicht verfügbar
Untersuchte Intervention
nicht verfügbar
Studientyp
nicht verfügbar
Studiendesign
nicht verfügbar
Ein-/Ausschlusskriterien
nicht verfügbar
nicht verfügbar
Primäre und sekundäre Endpunkte
nicht verfügbar
nicht verfügbar
Registrierungsdatum
nicht verfügbar
Einschluss des ersten Teilnehmers
nicht verfügbar
Sekundäre Sponsoren
nicht verfügbar
Weitere Kontakte
nicht verfügbar
Sekundäre IDs
nicht verfügbar
Angaben zur Verfügbarkeit von individuellen Teilnehmerdaten
nicht verfügbar
Weitere Informationen zur Studie
nicht verfügbar
Ergebnisse der Studie
Zusammenfassung der Ergebnisse
nicht verfügbar
Link zu den Ergebnissen im Primärregister
nicht verfügbar